Anzeige
Mehr »
Montag, 03.08.2026 - Börsentäglich über 12.000 News
Breaking News: SalesCloser neuer Kunde heißt Facebook…
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: 910292 | ISIN: FR0000038242 | Ticker-Symbol: QTL
Stuttgart
31.07.26 | 21:56
26,350 Euro
0,00 % 0,000
1-Jahres-Chart
LUMIBIRD SA Chart 1 Jahr
5-Tage-Chart
LUMIBIRD SA 5-Tage-Chart
RealtimeGeldBriefZeit
26,20027,30002.08.
26,30026,55031.07.

Aktuelle News zur LUMIBIRD Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
Leser Medien
27.07.LUMIBIRD: Photonics confirms strong growth with a 15.3% increase in the first half of 2026300PHOTONICS CONFIRMS STRONG GROWTH WITH A 15.3% INCREASE IN THE FIRST HALF OF 2026 Consolidated revenue rose by 7.4% (9.7% on a like-for-like basis) The LUMIBIRD Group (FR0000038242 - LBIRD) reported...
► Artikel lesen
24.07.LUMIBIRD: Lumibird strengthens its position in strategic laser technologies532LUMIBIRD STRENGTHENS ITS POSITION IN STRATEGIC LASER TECHNOLOGIES Sale of Lumibird's stake in Cilas Long-term industrial partnership with Cilas Lumibird takes over Laser MégaJoule's maintenance...
► Artikel lesen
17.07.IPG Photonics to acquire Lumibird Medical for €300 million11
LUMIBIRD Aktie jetzt für 0€ handeln
17.07.LUMIBIRD ENTERS INTO EXCLUSIVE NEGOTIATIONS FOR THE SALE OF ITS MEDICAL DIVISION TO IPG PHOTONICS CORPORATION958Lannion, 16 July 2026 - 11:00 pm LUMIBIRD ENTERS INTO EXCLUSIVE NEGOTIATIONS FOR THE SALE OF ITS MEDICAL DIVISION TO IPG Photonics Corporation A defining milestone in Lumibird's development, creating...
► Artikel lesen
17.07.IPG Photonics Corporation: IPG Photonics Announces Binding Offer to Acquire Lumibird Medical, Expanding IPG's Medical Laser Growth Platform264Creates a Scaled Medical Laser Platform, Accelerating IPG's Strategic Expansion in Advanced Solutions Expected to Be Accretive to Gross Margin, EBITDA, and Adjusted EPS MARLBOROUGH, Mass., July...
► Artikel lesen
18.05.Dividendenbekanntmachungen (18.05.2026)16.336 Unternehmen  ISIN-Code  Dividende (Währung)  Dividende (EUR)  A2A SPA  IT0001233417 - 0,104 EUR  AIR LIQUIDE SA  FR0000120073 - 3,7 EUR  ALCOA CORPORATION CDIS  AU0000339426  0,1 USD  0,086 EUR  ALLISON...
► Artikel lesen
28.04.Lumibird-Aktie stürzt nach enttäuschenden Quartalsumsätzen um 8,6 % ab2
27.04.LUMIBIRD: Q1 REVENUE UP +0.7% AND +4.1% AT CONSTANT EXCHANGE RATES697Lannion, 27 April 2026- 5:45 pm Q1 revenue up +0.7% and +4.1% at constant exchange rates The LUMIBIRD Group (FR0000038242 - LBIRD), the European leader in laser technologies, reported a 0.7% increase...
► Artikel lesen
08.04.LUMIBIRD MEDICAL ACCELERATES ASIA PACIFIC EXPANSION WITH FUTURE ACQUISITION OF BIZ MEDIC SDN BHD TO FORM NEW SOUTHEAST ASIAN HUB583Lannion, 8 April 2026 - 5:45 pm LUMIBIRD MEDICAL ACCELERATES ASIA PACIFIC EXPANSION WITH FUTURE ACQUISITION OF BIZ MEDIC SDN BHD TO FORM NEW SOUTHEAST ASIAN HUB The LUMIBIRD Group (FR0000038242...
► Artikel lesen
10.03.LUMIBIRD: 2025 ANNUAL RESULTS SHOW STRONG GROWTH1.106Lannion, 10/03/2026 - 5:45 pm 2025 annual results show strong growth EBITDA margin(1) of 20.2%, up +4.3 points Free cash flow of €13.1 million Implementation of a dividend distribution The...
► Artikel lesen
10.02.Lumibird-Aktie steigt nach Rüstungsauftrag von Rheinmetall69
09.02.LUMIBIRD: Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system1.496Lumibird was selected by Rheinmetall for the Skyranger 30 air defence system The LUMIBIRD Group (FR0000038242 - LBIRD), the European leader in laser technologies, announces that its subsidiary...
► Artikel lesen
26.01.LUMIBIRD: Lumibird: FY revenue of EUR 225.6 million (+10.2% at constant scope and exchange rates)611Lumibird: FY revenue of €225.6 million (+10.2% at constant scope and exchange rates) Growth of +10.2% at constant scope and exchange rates (+8.9% reported) Photonics Division: revenue of €113.4...
► Artikel lesen
23.09.25LUMIBIRD: H1 2025 RESULTS SHOW STRONG GROWTH IN BOTH DIVISIONS804Group EBITDA at €20.2 million (+85%), representing 18.9% of revenue Medical Division: EBITDA of €12.1 million, representing 21.8% of revenue (vs. 17.6% in H1 2024) Photonics Division: EBITDA...
► Artikel lesen
14 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1